Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 263.10K | 91.30K | 54.00K | 151.10K | 130.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 263.10K | 91.30K | 54.00K | 151.10K | 130.10K |
| Cost of Revenue | 70.10K | 28.20K | 27.70K | 39.20K | 59.20K |
| Gross Profit | 193.00K | 63.10K | 26.30K | 111.90K | 70.90K |
| SG&A Expenses | 216.80K | 105.50K | 123.30K | 106.90K | 132.00K |
| Depreciation & Amortization | 0.00 | -- | -- | 31.60K | 20.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 286.90K | 133.70K | 151.00K | 177.70K | 211.40K |
| Operating Income | -23.80K | -42.40K | -97.00K | -26.60K | -81.40K |
| Income Before Tax | -55.40K | -42.10K | -110.40K | -29.00K | -114.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.40K | -42.10K | -110.40K | -29.00K | -114.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.40K | -42.10K | -110.40K | -29.00K | -114.20K |
| EBIT | -23.80K | -42.40K | -97.00K | -26.60K | -81.40K |
| EBITDA | -23.80K | -42.40K | -97.00K | 5.00K | -61.10K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| Average Diluted Shares Outstanding | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |